Method of making implantable medical devices having controlled surface properties
First Claim
Patent Images
1. A method for controlling surface properties of an implantable medical device, comprising:
- a. vacuum depositing at least one device forming metal selected from one of elemental nickel, elemental titanium, chromium-cobalt alloy, nickel-titanium alloy and nickel-titanium ternary alloy onto a cylindrical substrate maintained at a temperature range between about 300 to 1100 degrees Centigrade, to form a tubular device forming biomaterial on the cylindrical substrate;
b. controlling the formation of heterogeneities at a blood or tissue contacting surface of the tubular device forming biomaterial during the vacuum depositing step, such that controlled heterogeneities are formed at the blood or tissue contacting surface; and
c. removing the formed biomaterial from the substrate.
1 Assignment
0 Petitions
Accused Products
Abstract
An implantable medical device that is fabricated from materials that present a blood or body fluid or tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of a monolithic material formed into differentiated regions defining structural members and web regions extending across interstitial spaces between the structural members. The endoluminal stent-graft is characterized by having controlled heterogeneities at the blood flow surface of the stent.
156 Citations
23 Claims
-
1. A method for controlling surface properties of an implantable medical device, comprising:
-
a. vacuum depositing at least one device forming metal selected from one of elemental nickel, elemental titanium, chromium-cobalt alloy, nickel-titanium alloy and nickel-titanium ternary alloy onto a cylindrical substrate maintained at a temperature range between about 300 to 1100 degrees Centigrade, to form a tubular device forming biomaterial on the cylindrical substrate; b. controlling the formation of heterogeneities at a blood or tissue contacting surface of the tubular device forming biomaterial during the vacuum depositing step, such that controlled heterogeneities are formed at the blood or tissue contacting surface; and c. removing the formed biomaterial from the substrate. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A method for controlling surface properties of an implantable medical device, comprising the steps of:
-
a. forming a tubular nickel-titanium alloy biomaterial onto a substrate maintained at a temperature range between about 300 to 1100 degrees Centigrade and non-zero bias voltage applied to the generally cylindrical substrate sufficient to impart a hyperthermal energy of energetic species arriving at the surface of the substrate to between about 0.1 eV and about 700 eV, the substrate having a pre-determined pattern of topographical features on an exterior surface thereof, wherein the pattern of topographical features comprises a positive or negative pattern that is imparted to the device forming biomaterial; b. controlling the formation of heterogeneities at a blood or tissue contacting surface of the biomaterial by fabricating the bulk material of the medical device to have a defined grain sizes that yield sites along the surface of the medical device having protein binding capability, wherein the controlled heterogeneities have a blood contact surface of diameter less than or equal to about 10 μ
m and an inter-heterogeneity boundary between about 0 and 2 μ
m; andc. removing the medical device from the substrate. - View Dependent Claims (11, 12, 13, 14, 15, 16)
-
-
17. A method for controlling surface properties of an implantable medical device, comprising:
-
a. vacuum depositing a generally tubular nickel-titanium alloy device onto a substrate, the substrate having a pre-determined pattern of recesses and the substrate is maintained at a non-zero bias voltage present between about −
1000 and +1000 volts applied to the generally cylindrical substrate sufficient to impart a hyperthermal energy of energetic species arriving at the surface of the substrate to between about 0.1 eV and about 700 eV;b. controlling the formation of heterogeneities at a blood or tissue contacting surface of the biomaterial during fabrication of the medical device, such that controlled heterogeneities are formed and have a substantially homogeneous surface energy and electrostatic charge across a blood contact surface of the metal film, wherein the controlled heterogeneities have a blood contact surface of diameter less than or equal to about 10 μ
m and an inter-heterogeneity boundary between about 0 and 2 μ
m; andc. removing the medical device from the substrate. - View Dependent Claims (18, 19, 20, 21, 22, 23)
-
Specification